✦ LIBER ✦

HER-2/Neuoverexpression does not predict response to neoadjuvant chemotherapy or prognosticate survival in patients with locally advanced breast cancer

✍ Scribed by Asma M. Tulbah; Ezzeldin M. Ibrahim; Adnan A. Ezzat; Dahish S. Ajarim; Mohammed M. Rahal; Amr N. El Weshi; Ralph Sorbris

Book ID: 111640852
Publisher: Springer US
Year: 2002
Tongue: English
Weight: 129 KB
Volume: 19
Category: Article
ISSN: 1357-0560
DOI: 10.1385/mo:19:1:15

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Angiogenesis does not predict clinical r

Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer

✍ Trond Paulsen; Turid Aas; Anne-Lise Borresen; Jan Erik Varhaug; Per E. Lønning; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 43 KB 👁 2 views

## Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer The prognostic importance of angiogenesis in breast cancer has recently been discussed, and a significant relationship between vascular density and survival has been descri

Complete pathological response in patien

Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy

✍ Heidy Cedeño; Rafael Araúz; Fernando Cebamanos; Idalmis de Torraza; Ana Porcell 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 135 KB

Assessment of Biomarker Expression in Pr

Assessment of Biomarker Expression in Predicting Pathologic Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer

✍ David C. Chhieng; Cristina Rodriguez-Burford; Sreelatha Meleth; William E. Grizz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB

Tumour molecular subtyping according to

Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer

✍ Alfonso Sánchez-Muñoz; Ana María García-Tapiador; Esther Martínez-Ortega; Rosari 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 464 KB

1002 POSTER The usefulness of FDG-PET in

1002 POSTER The usefulness of FDG-PET in predicting response to neoadjuvant chemotherapy (NCT) in patients with locally-advanced breast cancer (LABC)

✍ M.E. Schneider-Kolsky; P. Midolo; S. Hart; J. Stuckey; A. Baldey; J. Fox; P.A.W. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Insulin-like growth factor-1 receptor (I

Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neuoverexpressing metastatic breast cancer

✍ Wolfgang J. Köstler; Gernot Hudelist; Werner Rabitsch; Klaus Czerwenka; Ruth Mül 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 397 KB